Search by Drug Name or NDC

NDC 00904-7393-89 Droxidopa 300 mg/1 Details

Droxidopa 300 mg/1

Droxidopa is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by MAJOR PHARMACEUTICALS. The primary component is DROXIDOPA.

MedlinePlus Drug Summary

Droxidopa is used to treat symptoms (dizziness, lightheadedness, or a fainting sensation [feeling that you are about to black out]) of neurogenic orthostatic hypotension (a sudden fall in blood pressure that occurs when a person assumes a standing position caused by certain nervous system conditions). Droxidopa is in a class of medications called alpha and beta-adrenergic agonists. It works by increasing the levels of norepinephrine, a natural substance in the body.

Related Packages: 00904-7393-89
Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Droxidopa

Product Information

NDC	00904-7393
Product ID	0904-7393_04b1f69d-ebba-43b9-8ecd-4f6be7c8a0a0
Associated GPIs
GCN Sequence Number	072024
GCN Sequence Number Description	droxidopa CAPSULE 200 MG ORAL
HIC3	J5H
HIC3 Description	ADRENERGIC VASOPRESSOR AGENTS
GCN	36089
HICL Sequence Number	040936
HICL Sequence Number Description	DROXIDOPA
Brand/Generic	Generic
Proprietary Name	Droxidopa
Proprietary Name Suffix	n/a
Non-Proprietary Name	Droxidopa
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	300
Active Ingredient Units	mg/1
Substance Name	DROXIDOPA
Labeler Name	MAJOR PHARMACEUTICALS
Pharmaceutical Class	Catecholamines [CS], Increased Blood Pressure [PE]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA211741
Listing Certified Through	2025-12-31

Package

NDC 00904-7393-89 (00904739389)

Pricing Information	N/A
NDC Package Code	0904-7393-89
Billing NDC	00904739389
Package	90 CAPSULE in 1 BOTTLE (0904-7393-89)
Marketing Start Date	2023-12-28
NDC Exclude Flag	N